Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05617391 · ClinicalTrials.gov registry record
An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive Risks
A clinical trial of Childhood Cancer and Cardiomyopathy, Primary, sponsored by St. Jude Children's Research Hospital.
- Active
- Registry status
- 1,303
- Enrollment target
- 1
- Study location
NCT05617391 is a study of Childhood Cancer and Cardiomyopathy, Primary that is active but no longer recruiting, run by St. Jude Children's Research Hospital. The registered enrollment target is 1,303 participants, roughly in line with the 1,415-participant average among 23 other Childhood Cancer trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT05617391, a study of Childhood Cancer and Cardiomyopathy, Primary, is active but no longer recruiting, sponsored by St. Jude Children's Research Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 1,303 participants
- Enrollment target
- 1
- Study location
Study Summary
The participant is being asked to take part in this trial, because the participant is a survivor of childhood cancer. Primary Objective To evaluate remote cardiomyopathy prediction via smartwatch and one clinical ECG and assess the concordance of the two ECGs in terms of predicted risk. Secondary Objective To build a novel predictive model solely on smartwatch ECG to predict risk for cardiomyopathy.
Conditions Studied
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,303 participants |
| Start Date | 2022-12-13 |
| Est. Completion | 2027-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05617391
The ClinicalTrials.gov registry entry for NCT05617391 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,303 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 1,415-participant average among 23 other Childhood Cancer trials with a reported enrollment target. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Childhood Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT05617391 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT05617391 about?
NCT05617391 is a clinical study titled "An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive Risks". The participant is being asked to take part in this trial, because the participant is a survivor of childhood cancer. Primary Objective To evaluate remote cardiomyopathy prediction via smartwatch and one clinical ECG and assess the concordance of the two ECGs in terms of predicted risk. Secondary...
What is the current status of trial NCT05617391?
This trial is currently active not recruiting. The enrollment target is 1,303 participants. The study started on 2022-12-13. Estimated completion is 2027-06.
What conditions does trial NCT05617391 study?
This clinical trial studies the following conditions: Childhood Cancer, Cardiomyopathy, Primary.
Who is sponsoring clinical trial NCT05617391?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05617391 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preparing for Life and Academics for Young Childhood Cancer Survivors
RECRUITING · NA
-
Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
RECRUITING · NA
-
Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
RECRUITING · NA
-
Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors
RECRUITING · NA
-
Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care
RECRUITING · NA
-
Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.